Cheng Han Ng

#LiverTwitter Grateful to be listed (again) in Stanford’s Top 2% Scientists this year 🧑‍🔬📊& 2nd year in a row 🙏 Big thanks to mentors, collaborators & colleagues who make the journey possible. Excited to keep learning & building 🚀✨

Just published our meta-analysis in Cell Reports Medicine. Across 33 RCTs, we find that a substantial fraction of patients on semaglutide have suboptimal responses—especially in type 2 diabetes. The key issue isn’t efficacy, but heterogeneity. 🔗 cell.com/cell-reports-m…

Join us at #METABOASIA2026 — a one-day biotech & translational science forum in Singapore 🇸🇬📍 8 July 2026 | NUS Medicine (MD6). Interactive panels on MASH, CVD, obesity & sarcopenia + siRNA, metabolomics & more. 🎤 Call for oral presentations!

#LiverTwitter Happy to see our latest article published in the @AmJGastro on the diagnostic evaluation of imaging modalities to identify at risk MASH! 😍 FAST, MRE provides the best evidence to independently identify at risk MASH. 🔍 journals.lww.com/ajg/abstract/9…

@wangyc_zd my wife can HAHA

@ChengHanNg You can write Japanese? 👍🏻

研究から2年間離れていましたが、今年3月25日に復帰しました。短期間でのチームの大きな進展を見てとても嬉しく思います。次の章に向けて、高橋教授との今後の共同研究、そしてシンガポールと日本をつなぐ若手日本人医師との連携を共有できることを楽しみにしています。 「肝創 Liver Innovation!」

Just published 2 studies on MASLD! (a) MASLD in adolescents is rising sharply through 2035 (jhep-reports.eu/article/S2589-…) (b) we also show a growing burden of steatotic liver disease in women (pubmed.ncbi.nlm.nih.gov/41260489/)

Excited to share our new paper in Liver Transplantation🚀 We used generative AI to uncover latent weight-trajectory patterns after liver transplantation, explaining ~99% of post-LT weight change. MASH cirrhosis and male sex as key predictors. journals.lww.com/lt/abstract/99…

#LiverTwitter While I was unable to attend #TLM2025 , very happy to see my CORE (cirrhosis outcomes and research endeavour) continues its growth to 20 sites in 1 year! 😍 We have completed and submitted 3 manuscripts, collected over 4000 patients and working on another 5 papers!

@DrHuangDQ @doctornikkid I thought recently there’s a news abt some ban cause of food coloring issue 😂

@doctornikkid Yes, good stuff. Also great at inducing mash

The hardworking (and long-suffering) research team having a pre-lab meeting feast

#LiverTwitter Excited to share our latest study in @AGA_CGH Using >44,000 SRTR waitlist registrants, we found that while MELD 3.0 reclassifies many MASH patients, it doesn’t translate into better transplant access despite higher predicted mortality risk. cghjournal.org/article/S1542-…

#LiverTwitter Our new study published in APT! where "Less than 10% of patients received the recommended biannual ultrasound scans for surveillance."😱 onlinelibrary.wiley.com/doi/10.1111/ap… @KarnJUVE @nogamia_liver @DrHuangDQ @DrMarkMuthiah @PojsakornDan